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Numerous difficulties are associated with the conduct of preclinical studies related to skin and wound repair.
Use of small animal models such as rodents is not optimal because of their physiological differences to human
skin and mode of wound healing. Although pigs have previously been used because of their human-like mode
of healing, the expense and logistics related to their use also renders them suboptimal. In view of this, alter-
natives are urgently required to advance the field. The experiments reported herein were aimed at developing
and validating a simple, reproducible, three-dimensional ex vivo de-epidermised dermis human skin equivalent
wound model for the preclinical evaluation of novel wound therapies. Having established that the human skin
equivalent wound model does in fact ‘‘heal,’’ we tested the effect of two novel wound healing therapies. We also
examined the utility of the model for studies exploring the mechanisms underpinning these therapies. Taken
together the data demonstrate that these new models will have wide-spread application for the generation of
fundamental new information on wound healing processes and also hold potential in facilitating preclinical
optimization of dosage, duration of therapies, and treatment strategies prior to clinical trials.
Introduction
Skin, the largest organ in the body, performs manyimportant roles, such as barrier protection from physical
or chemical insults, sensory functions, and regulation of ho-
meostasis. However, damaged skin cannot perform these
critical functions and numerous complications such as infec-
tion or fluid loss can occur.1 Our current understanding of the
biological processes underlying wound repair, along with
maintenance of skin function and integrity, is limited. This
lack of knowledge has arisen in part from the less than ideal
in vitro and ex vivo models available for fundamental skin
research. The development of improved models is therefore
critical to advance our understanding of human skin repair
and regeneration.2 In particular, improved models are re-
quired to facilitate the development and preclinical evalua-
tion of wound therapies. Wounds represent a significant
and increasing burden on healthcare systems globally and
new therapies and wound management approaches are ur-
gently required. The experiments reported herein were
therefore aimed at critically evaluating and refining a three-
dimensional (3D) ex vivo de-epidermised dermis (DED)
human skin equivalent (HSE)model for preclinical evaluation
of wound therapies.
Several HSE models have previously been developed with
various dermal substrates, including DED,3,4 alloderm,5
collagen matrices with or without glycosaminoglycans and
fibroblasts,6–8 as well as scaffolds of benzyl ester of semi-
synthetic hyaluronan seeded with fibroblasts.9 The model
that we utilized, the DED-HSE, is often considered more
physiologically relevant as it incorporates a human acellular
dermis to create a multilayered epidermis and retains the
basement membrane. This has been previously shown to be
critical for keratinocyte attachment in vitro.10,11
Several approaches have been used to create wounds and
for studying wound responses in excised skin and=or in vivo
models, including scratch tests,12,13 tape abrasion,14
burns,15,16 thermal injury,17 suction blisters,18 use of
electrokeratome=dermatomes,19,20 scalpels,21–24 meshers,25,26
biopsy punches,27–32 liquid nitrogen,22 and lasers.33 However,
a reproduciblewoundwith a given size anddepth in an ex vivo
DED-HSE model has yet to be reported. The study reported
here therefore focused on the development of simple and re-
producible models of wound healing using biopsy punches to
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create wounds in the DED-HSEs. To validate the wound
model we tested the effect of two novel wound healing ther-
apies—a vitronectin:growth factor (VN:GF) complex cur-
rently in clinical trials and a synthetic biomimetic gel.
Methods
Approval was obtained from the Queensland University
of Technology Review Board and written informed consent
was obtained from patients undergoing elective abdominal
and breast reduction surgeries before skin collection. The
study was conducted with strict adherence to the Declaration
of Helsinki Principles.
Cell isolation and culture
Keratinocytes were isolated from the skin collected from
surgical discards and cultured in Full Green’s (FG) medium34
following previous protocols.35 For fibroblast isolation, der-
mal pieces were finely minced (0.2!0.2 cm) and immersed in
0.05% collagenase A (type I; Invitrogen, Mulgrave, Australia)
solution in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen) at 378C, 5% CO2 for 18 h. The enzyme solution
was then centrifuged at 2000 rpm for 10min. Cells were
seeded into T80 flasks in 10% fetal bovine serum in DMEM
and cultured at 378C, 5% CO2.
Construction of DED-HSE
The decellularized DED was prepared as described pre-
viously4 with modifications.35 Sterile stainless-steel rings
with an internal diameter of 9mm were placed onto the
papillary side of each DED piece (1.8 cm!1.8 cm). Keratino-
cytes (passage 1, 3.6!104) were transferred into the ring
placed on the DEDs and incubated for 2 days. The rings were
removed and the DED-HSEs were then lifted to the air:liquid
interface using a stainless-steel grid in approximately 6mL of
FG medium.
2D multiphoton microscopy images
The DED-HSEs prepared as described above were cul-
tured in FG medium for 4 days at the air:liquid interface at
378C, 5% CO2. Samples were then scanned using a Multi-
photon Microscope ( JenLab GmbH, Jena, Germany) and
cellular autofluorescence was recorded every 2mm at depths
from 0 to 150mm.
Use of the DED-HSE model for function-blocking
antibody studies
The DED-HSEs were prepared as described earlier. At the
time of being lifted to the air:liquid interface, the DED-HSEs
were treated with topical applications of 40 mL VN:GF (0.6 mg
VNþ 0.6 mg insulin-like growth factor [IGF] binding protein
3 [IGFBP3]þ 0.2 mg IGFþ 0.2 mg epidermal growth factor
[EGF]) (Tissue Therapies, Brisbane, Australia); 36 mL of
VN:GF (0.54 mg VNþ 0.54 mg IGFBP3þ 0.18 mg IGFþ 0.18 mg
EGF)þ anti-IGF-1 receptor antibody (anti-IGF-1R) (1:10;
Calbiochem, Darmstadt, Germany); or 40mL of VN:GF
(0.6 mg VNþ 0.6 mg IGFBP3þ 0.2 mg IGFþ 0.2 mg EGF)þ
nonspecific IgG1 subtype (IgG) (1: 500; Chemicon, Temecula,
CA). After 7 days of culture at the air:liquid interface, the
DED-HSEs were stained with methylthiazol tetrazolium
(MTT) and fixed for histological analysis.
Fabrication of the partial-thickness DED-HSE wound
model and assessment of the VN:GF
and the synthetic biomimetic gel
After 9 days culture at the air:liquid interface, 6mm
partial-thickness excisional wounds were created in the
DED-HSEs with a 6mm biopsy punch (Stiefel, Castle Hill,
Australia) excising through the epidermis. The epidermis
was then peeled away from the DED with forceps and dis-
carded. To assess the effect of VN:GF in wound healing,
wounded areas of the DED-HSEs were cultured with 6mL
of FG, VN:GF (0.23 mg=mL VN, 0.23 mg=mL IGFBP3,
0.08 mg=mL IGF and 0.08 mg=mL EGF), or serum-free media
(SFM) media at the air:liquid interface for 3, 7, and 12 days.
To evaluate the effect of the synthetic biomimetic gel,36,37 the
wounded areas of the DED-HSEs were treated with either
topical application of 13 mL of gel (2.25%, w=v) or 13 mL of FG
(positive control) for 7 days. Samples were then stained with
MTT, hematoxylin and eosin, or immunohistochemistry and
analyzed microscopically as described previously.16
Fabrication of the full-thicknessDED-HSEwoundmodel
and assessment of the synthetic biomimetic gel
Sterile stainless-steel rings with an internal diameter of
6.7mm were placed on the papillary (for seeding of kerati-
nocytes) or reticular (for seeding of fibroblasts) face of the
DEDs. Keratinocytes and fibroblasts (2.0!104 per ring) were
seeded into the center of the rings. The DED-HSEs were
seeded with cells and incubated at 378C, 5% CO2 as follows:
for DED-HSEs seeded with keratinocytes alone, cells were
seeded for 48 h; for DED-HSEs seeded with fibroblasts alone,
cells were seeded for 72 h; for DED-HSEs seeded with kera-
tinocytes and fibroblasts together, fibroblasts were seeded
for 72 h and keratinocytes were then seeded on top of fi-
broblasts for a further 48 h. The DED-HSEs were then lifted
to the air:liquid interface. After 7 days, 4mm diameter full-
thickness incisional wounds were created in the DED-HSEs
using a 4mm biopsy punch (Stiefel), which cut through all
the layers of the DED-HSEs, both epidermal and dermal.
This was followed by removal of the 4mm diameter
epidermal=dermal core. The wounds were injected with 13mL
of synthetic biomimetic gel (2.25%, w=v) or collagen gel. The
wounded DED-HSEs were probed using histology and im-
munofluorescence after 14 days.
Formation of synthetic biomimetic gel
and the collagen-I hydrogel
Synthetic biomimetic gels were produced as previously
described.36,37 Briefly, peptides containing complementary
substrates for FXIII-catalyzed crosslinking, NQEQVS
PLERCG-NH2 (TG-Gln) or Ac-FKGGGPQG ; IWGQERCG-
NH2 (TG-MMP-Lys; NeoMP, Strasbourg, France), were
grafted onto eight-arm poly(ethylene glycol) macromolecules
(8-PEG,Mw 40 kDa) yielding the hydrogel precursors 8-PEG-
Gln and 8-PEG-MMP-Lys, respectively. After the coupling
reactions the solutions were dialyzed against ddH2O and
were subsequently freeze-dried. The TG-MMP-Lys peptide
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also includes a matrix metalloproteinase (MMP) substrate
(underlined; ; indicates cleavage position) to render the final
hydrogels susceptible to proteolytic degradation. For syn-
thetic biomimetic gels insensitive to MMP degradation, the
8-PEG-MMP-Lys precursor was replaced by 8-PEG-noMMP-
Lys in which the MMP-degradable substrate was substituted
by the MMP-insensitive sequence -GDQGIAGF- (NeoMP).
Gels were subsequently formed by FXIII-catalyzed cross-
linking of stoichiometrically balanced 8-PEG-Gln and 8-PEG-
MMP-Lys (for MMP-sensitive gels) or 8-PEG-noMMP-Lys
(for MMP-insensitive gels) in Tris buffer (TBS, 50mM, pH
7.6) containing 50mM calcium chloride and 10.7U=mL ac-
tivated FXIII. For example, to produce 120 mL of 5% (w=v)
hydrogel matrices the following solutions were used:
43.17 mL (8-PEG-Gln, 67.64mg=mL), 45.83mL (8-PEG-MMP-
Lys or 8-noMMP-Lys, 67.20mg=mL), 19 mL spare volume (for
the incorporation of RGD-peptide or Tris buffer for blank
gels), 6mL calcium chloride (1M), and 6 mL of activated FXIII
(213.5U=mL; kindly donated by Baxter, Vienna, Austria). For
hydrogels with 1.5% and 2.25% (w=v) dry mass, the pre-
cursor solutions were diluted accordingly. RGD-functiona-
lized hydrogels (50mM) were produced by addition of the
peptides NQEQVSPL-GRGDSPG-NH2 (TG-Gln-RGD).
Crosslinking reactions were performed at 378C and 5% CO2
humidified atmosphere for 30–40min.
Collagen gels were produced from a single batch of rat tail
collagen type I solution (BD Biosciences, North Ryde, Aus-
tralia). Specifically, to produce a 100mL volume of gel, 89.6 mL
of collagen-I stock solution (3.35mg=mL), 2.42 mL sodium
hydroxide (1M), and 8 mL of 10!phosphate-buffered saline
(PBS; Oxoid, Victoria, Australia) were used. Collagen-I hy-
drogels were formed at 378C, in a 5% CO2 atmosphere for
60min.
Immunofluorescence
The full-thickness wounded DED-HSEs injected with
synthetic biomimetic gels were probed for nuclei (40-6-
diamidino-2-phenylindole [DAPI], 1:2000; Vector Labora-
tories, Burlingame, CA), F-actin (phalloidin rhodamine)
(1:250; Molecular Probes, Eugene, OR), and pan-cytokeratin
(1:100; Dako, Botany, Australia) expression. The wounded
DED-HSE samples were fixed and permeabilized in 4%
formalin containing 0.2% Triton X-100 in PBS for 20min at
208C. Glycine (0.1M) was added to quench free aldehydes.
After washing samples three times for 5min in phosphate-
buffered saline, the wounded DED-HSEs were stained with
phalloidin or DAPI, for 45min at room temperature. For pan-
cytokeratin, samples were blocked in 1% (w=v) bovine serum
albumin=PBS for 1 h and incubated with a AE1=AE3 primary
antibody anticytokeratin for 45min, followed by incubation
with a second antibody anti-mouse immunoglobulins=
fluorescein isothiocyanate (1:200; Dako) conjugate for 45min.
Epifluorescence images were captured using a TE2000 in-
verted microscope (Nikon, San Francisco, CA) and a Leica
TCS SP5 confocal laser scanning microscope (Leica Micro-
systems, Wetzlar, Germany) at lex¼ 356 nm, lem¼ 461 nm
for DAPI=nuclei visualization; lex¼ 557 nm, lem¼ 574 nm
for phalloidin rhodamine=actin filament visualization; and
lex¼ 495 nm, lem¼ 515 nm for fluorescein isothiocyanate=
pancytokeratin visualization.
Statistics
Means$ standard error of the mean are presented. Du-
plicate DED-HSEs were tested individually with each treat-
ment within each assay, and the entire experiment was
repeated three times. The DEDs and cells for each replicate
experiment were isolated from three different donors. The
data were pooled from three replicate experiments in which
each treatment was tested in duplicate. One-way analysis of
variance with Tukey’s post hoc tests (all group comparisons)
were used to analyze the data. Statistically significant dif-
ferences were determined as p< 0.05.
Results
Similarity between native human skin
and the DED-HSE
To compare the DED-HSE constructed as described in the
methods with native human skin, samples were first investi-
gated using multiphoton microscopy. The multiphoton mi-
croscopy enables the nondestructive examination of cellular
changes, such as morphology, in real-time. For the DED-HSE,
as seen in Figure 1a, the stratum corneum appeared bright
with strong contrast because of a high concentration of the
endogenous fluorophore keratin. Fifty micrometers below the
surface, the stratum spinosum was visualized and exhibited
dense cell formation and decreasing cell diameter. Keratino-
cytes could be clearly separated (Fig. 1b). At depths of 100–
150mm below the surface, the innermost epidermal cell layer
(stratum basale) was found (Fig. 1c). Basal keratinocytes ap-
peared as small and polygonal cells with dark nuclei. The
dark and oval areas, which correspond to the connective tis-
sue of the papillary dermis, were observed interrupting the
stratum basale. For the native skin, the captured images
showed similar cellular morphology and organization to the
DED-HSE (Fig. 1d–f ). These data indicate that morphology
and organization of keratinocytes between ex vivo skin and
the DED-HSE were comparable.
Development and validation of a 6mm diameter
partial-thickness DED-HSE wound model
To determine an appropriate protocol for creating a re-
producible partial-thickness wound, the DED-HSEs were
cultured at the air:liquid interface for 7, 9, and 11 days, and
the epidermis was peeled from each DED-HSE after excision
with a 6mm biopsy punch (Fig. 2a). We found that the
epidermis of DED-HSEs cultured for 7 days would not
separate from the dermis (Fig. 2b) with many keratinocytes
remaining attached to the dermis in the area of excision.
However, after 9 days the epidermis could be removed from
the dermis. Although the epidermis could be peeled away as
a whole piece from the dermis after 11 days, the majority of
cells at the edge of the defect displayed a differentiated
phenotype, as determined by histology.
To establish that the wounded DED-HSEs were capable of
healing, the constructs were cultured in serum-containing FG
medium34 for 3, 7, and 12 days, respectively. The uncovered
wound area, as revealed by MTT assay, decreased from
26.49$ 1.18mm2 at day 0 to 19.11$ 3.44mm2 at day 3, to
11.25$ 2.58mm2 at day 7, and to 7.53$ 2.92mm2 at day 12
(Fig. 2c, d).
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Histological analysis allowed evaluation of the wounded
DED-HSEs throughout the healing process (Fig. 2c, e).
After 3 days the wound bed of the DED-HSEs was par-
tially covered by a wedge-shaped ‘‘epithelial tongue,’’
two to three cells in depth. After 7 days, a monolayer or
bilayer of keratinocytes covered the center and a more
stratified epithelium was evident toward the wound
margins. A stratified epithelium covered the entire area at
day 12. The lateral migration of keratinocytes (distance from
two of the wound edges to the center of the wound in the
DED-HSEs) increased from zero at day 0, to 1.19$ 0.51mm
after 3 days, to 3.10$ 0.63mm after 7 days, and to
4.18$ 0.77mm after 12 days. Taken together, these data
indicate that the wound in the DED-HSE is capable of
‘‘healing.’’
Immunohistochemistry was undertaken to detect the ex-
pression of specific markers on the surface of cells in the
wounded DED-HSEs (Fig. 2f ). Immunohistochemical anal-
ysis with a monoclonal antibody raised against the nuclear
transcription factor p63 revealed the presence of undiffer-
entiated proliferating cells. At day 3, intense immunoreac-
tivity of p63 was detected in keratinocytes located at the
edge of the wound within the suprabasal and basal layers of
the wounded DED-HSEs. However, the immunoreactivity
was decreased at day 7 and limited to the deeper basal layers
at day 12. Immunohistochemical analysis with a monoclonal
antibody raised against keratins 1, 10, and 11 revealed the
presence of differentiated cells. The positive immunoreac-
tivity of keratins 1, 10, and 11 was present at the edge of the
wounded DED-HSEs at days 3, 7, and 12.
FIG. 1. Multiphoton microscopy images of the de-epidermised dermis human skin equivalent (DED-HSE) (a–c) and the
native human skin (d–f). Skin samples were scanned using multiphoton microscopy. Images captured at different tissue
depths reveal the stratum corneum (a, d), the stratum spinosum (b, e), and the basal layer (c, f). Autofluorescence was
recorded in 2mm increments, up to 150mm below the surface. Scale bar: 300 mm.
FIG. 2. Development and validation of a 6mm diameter superficial-thickness DED-HSE wound model. (a) Photograph of
technique used to create the superficial-thickness wound in the DED-HSE. A wound was created using a 6mm biopsy punch,
followed by the removal of a central portion of the epidermis with forceps. (b) Methylthiazol tetrazolium (MTT) (left panels)
and histological analysis (right panels). A 6mm superficial-thickness wound was created in individual DED-HSE after culture
at the air:liquid interface for 7, 9, and 11 days. Dashed lines indicate the wound boundaries. (c) Representative images of MTT
and hematoxylin and eosin-stained DED-HSEs during repair. Samples were cultured with Full Green’s (FG) medium for 3, 7,
and 12 days after superficial-thickness wounds were created. Dashed lines indicate the wound boundaries. (d) Quantification
of the uncovered wound area and (e) the lateral migration of keratinocytes. (f) Representative images of the p63 and keratins
1, 10, and 11 (K1=10=11) expression in DED-HSEs during repair. n¼ 6; *p< 0.05. Scale bars: 6mm (a), 0.6mm (b), 3mm
(c, top), 300 mm (c, bottom), and 100 mm (f). Color images available online at www.liebertonline.com=ten.
‰
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FIG. 3. Investigation of the effect of vitronectin:growth factor (VN:GF [VG]) on healing of superficial-thickness wounds.
Representative images of (a) MTT and (b) histological analysis of the wounded DED-HSEs. Samples were cultured with FG,
VN:GF, and serum-free media (SFM) for 3, 7, and 12 days after the creation of 6mm superficial-thickness wounds. Dashed
lines indicate the wound boundaries. Quantification of (c) uncovered wound area and (d) lateral migration of keratinocytes.
(e, f) Mechanistic investigation using the DED-HSEs. Samples were topically treated with VN:GF, VN:GFþ IGF-1R Ab, and
VN:GFþ IgG (nonspecific IgG1 subtype) for 7 days. n¼ 6; *,#p< 0.05. Scale bars: 3mm (a), 300 mm (b), and 50mm (e). Color
images available online at www.liebertonline.com=ten.
1116
Investigation of the effect of VN:GF
on partial-thickness wound healing
Wounded DED-HSEs were cultured with serum-contain-
ing FG, VN:GF, or SFM and the area of the exposed DED
was measured. The uncovered wound area cultured with FG
and VN:GF treatments reduced from 26.49$ 1.18mm2at day
0 to 15.91$ 4.29 and 18.54$ 3.75mm2 at day 3, to 10.9$ 4.07
and 9.56$ 2.17mm2 at day 7, and to 7.64$ 3.51 and
6.44$ 1.70mm2 at day 12, respectively, as revealed by MTT
assay (Fig. 3a, c). These areas were significantly smaller
( p< 0.05) than those observed in DED-HSEs treated with
SFM at days 7 and 12.
The wounded DED-HSEs were also investigated through
histological analysis (Fig. 3b, d). The wound beds of DED-
HSEs cultured with either FG or VN:GF treatments were
partially covered by a wedge-shaped ‘‘epithelial tongue,’’
two to three cells in thickness, after day 3; a monolayer or
bilayer of keratinocytes in the center and a more stratified
epithelium toward the wound margins were evident at day
7. A fully stratified epithelium was present after 12 days. In
contrast, DED-HSEs cultured with SFM exhibited only a few
keratinocytes encroaching from the edge of the wound after
day 3 and these disappeared by day 7. The lateral migration
of keratinocytes cultured with FG and VN:GF treatments
increased from zero at day 0 to 1.73$ 0.54 and
2.10$ 0.92mm at day 3, to 3.49$ 0.92 and 3.44$ 0.35mm at
day 7, and to 4.12$ 0.99 and 4.67$ 0.47mm at day 12, re-
spectively. Again, these distances were significantly greater
( p< 0.05) than those observed on DED-HSEs cultured with
SFM (0$ 0mm). Taken together, these data indicate that the
wound area in DED-HSEs cultured with FG and VN:GF
treatments continued to decrease, whereas the wounds in
DED-HSEs cultured with SFM remained uncovered.
To validate the potential of the model for studies explor-
ing the mechanisms underpinning the VN:GF-complex-
stimulated migration, proliferation, and differentiation of
keratinocytes, the DED-HSEs were treated daily with VN:GF,
VN:GFþ IGF-1R Ab (anti-IGF-1 receptor antibody), and
VN:GFþ IgG (nonspecific IgG1 subtype) for 7 days. These
treatments have been examined in 2D cell monolayer previ-
ously by our laboratory and demonstrated that the enhanced
cellular functions stimulated by the VN:GF complex involve
the IGF receptor (IGF-1R).38 In the 3D DED-HSE studies re-
ported herein, the thickness of the epidermis in the DED-HSEs
exposed to these three treatments were 170.42$ 2.9, 80.99$
2.32, and 161.45$ 4.37 mm, respectively (Fig. 3e, f ). This in-
dicates that the IGF-1R Ab can significantly block the effect of
VN:GF on epidermal formation and also demonstrates that
the 3D DED-HSE model has utility for mechanistic studies.
Investigation of the effect of a synthetic biomimetic
gel on partial-thickness wounds
The partial-thickness wounded DED-HSE model was also
utilized to assess the effect of a synthetic biomimetic gel.36,37
Hydrogel with RGD peptides (the synthetic biomimetic gel),
hydrogel without RGD peptides, and serum-containing FG
medium were topically applied to the wounds and were
assessed along with controls with no treatment (Fig. 4). The
area of the wound remaining uncovered with keratinocytes
in DED-HSEs were 2.13$ 1.05mm2 (hydrogel with RGD
peptides), 3.64$ 1.14mm2 (hydrogel without RGD peptides),
8.33$ 2.22mm2 (positive control FG medium), and
10.70$ 1.50mm2 (no treatment), respectively (Fig. 4a, b).
The morphology of keratinocytes in the wounded DED-
HSEs was examined through histological analysis (Fig. 4a).
After day 7 the wound bed of DED-HSEs treated with hy-
drogel containing RGD peptides was almost completely
covered with a stratified epithelium. On the other hand,
wounded areas of DED-HSEs treated with the positive con-
trol FG medium, or no treatment, were only partially cov-
ered by multilayers of keratinocytes in the center and a more
stratified epithelium toward the wound margins. After 7
days the lateral migration of keratinocytes in wounds treated
with hydrogel with RGD peptides, hydrogel without RGD
peptides, FG medium, and no treatment were 4.66$ 0.54,
4.42$ 0.62, 3.73$ 1.01, and 2.46$ 0.21mm, respectively (Fig.
4c). These results indicate that the synthetic biomimetic gel
can significantly enhance keratinocyte reepithelialization.
Development of a full-thickness DED-HSE wound
model (seeded with keratinocytes and fibroblasts
alone and together) and investigation of the synthetic
biomimetic gel in full-thickness wound healing
To investigate the effect of the synthetic biomimetic gel in
full-thickness wound healing, full-thickness wounds were
created using a 4mm biopsy punch excising through the full
depth of the DED-HSE and removing the epidermal=dermal
core (Fig. 5a). The excised wound in the DED-HSEs were
then filled with the synthetic biomimetic gel and analyzed
with immunofluorescence. When DED-HSEs seeded with
keratinocytes alone were wounded, no cells were detected in
the wound after 14 days (Fig. 5b). Conversely, when DED-
HSEs seeded with fibroblasts alone were wounded, a large
number of fibroblasts were found to have migrated into the
wound (Fig. 5c). For the wounded DED-HSEs produced with
keratinocytes and fibroblasts cocultured together, keratino-
cytes migrated across the wound as detected by pan-
cytokeratin expression (Fig. 5d).
The morphology of the wounded DED-HSEs was also
investigated through histological staining. When DED-HSEs
seeded with fibroblasts alone were wounded, the fibroblasts
had migrated into the synthetic biomimetic gel (Fig. 5f ).
Curiously, when DED-HSEs seeded with keratinocytes alone
were wounded, the keratinocytes migrated along the dermis
at the edge of the wound rather than migrating across the
wound (Fig. 5e). With DED-HSEs that had been cocultured
with keratinocytes and fibroblasts together and were then
wounded, histological analysis confirmed that the keratino-
cytes migrated into the wound area (Fig. 5g). Taken together,
these results indicate that the synthetic biomimetic gel was
able to support the migration and proliferation of fibroblasts,
as well as keratinocytes, albeit only in the presence of
fibroblasts.
Further investigation of the cellular responses
to the synthetic biomimetic gel
To further characterize the synthetic biomimetic gel, full-
thickness wounds in the DED-HSEs seeded with fibroblasts
were filled with hydrogels with=without MMP cleavage sites
and RGD peptides.36,37 Immunofluorescent analysis revealed
significant differences in cellular responses to hydrogels with
and without incorporated MMP cleavage sites or RGD
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peptides (Fig. 6). When wounded DED-HSEs were treated
with collagen gel or hydrogel incorporating the MMP
cleavage sites and RGD peptides (the synthetic biomimetic
gel), large numbers of fibroblasts were found migrating
within the hydrogel in the wound area. Conversely, when
the wounded DED-HSEs were left untreated, or treated with
hydrogel without MMP cleavage sites or without RGD
peptides, few cells were observed to migrate into the gel
filling the wounds. These data indicate that the RGD pep-
tides and MMP cleavage sites have a significant influence on
the migration and proliferation of fibroblasts into the syn-
thetic biomimetic gel.
Discussion
Many challenges are associated with conducting relevant
fundamental and preclinical studies of human skin mainte-
nance and wound repair; however, HSE models are emerg-
ing as promising candidates. In particular, HSEs
incorporating DED appear to be superior, predominantly
because of their anatomical, structural, and functional simi-
larities to human skin.39 The study reported herein provides
further confirmation of the similarities between native
human skin and DED-HSEs using a novel technique, multi-
photon microscopy. Thus we showed that the DED-HSEs
have cellular morphology and organization consistent with
native human skin (Fig. 1).
To efficiently evaluate the efficacy of novel wound healing
therapies, a reliable and reproducible 3D human skin wound
model that more closely represents the in vivo environment,
as well as contains cells and proteins that are human in
origin, is clearly required. This study was therefore directed
at developing a reproducible partial-thickness DED-HSE
wound model. The partial-thickness DED-HSE wound
FIG. 4. Investigation of the effect of a synthetic biomimetic gel on repair of superficial-thickness wounds. Synthetic bio-
mimetic gels were injected into 6mm superficial-thickness wounds created in the DED-HSEs and cultured at the air:liquid
interface for 7 days. (a) Representative images of MTT and (b) hematoxylin and eosin-stained DED-HSEs during repair.
Superficial-thickness wounds in DED-HSEs were topically treated with gel with RGD peptides (GelþRGD), gel without
RGD peptides (Gel%RGD), FG medium, and no treatment (NT) for 7 days. The dashed lines indicate the initial boundary of
the wounds. Quantification of the uncovered wound area (b) and lateral migration (c) of keratinocytes from the wound edge
to the center of the wound. n¼ 6; *p< 0.05. Scale bars: 3mm (a, top) and 300mm (a, bottom). Color images available online at
www.liebertonline.com=ten.
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model reported herein, created by excising a central portion
of the epidermis through use of a 6mm biopsy punch,
demonstrated the ability to ‘‘heal,’’ as revealed by MTT and
histology. Interestingly, the repaired epithelial layer formed
had a similar morphology and keratin marker expression
profile to that reported in other studies in humans.27,40
(Fig. 2)
Odland and Ross have previously reported the creation of
partial-thickness skin incisions in humans to study wound
repair. They demonstrated that the cells at edges of the in-
cision started to migrate as an ‘‘epithelial tongue’’ within 48 h
after wounding. The reepithelialization was reported to be
complete within 72 h and a well-stratified epithelium was
formed by 96 h after wounding.40 This is somewhat faster
than the healing response we observed in the DED-HSEs.
However, this difference is most likely due to the fact that
Odland and Ross40 used an incisional wound in humans,
and our studies used excisional wounds in DED-HSEs. All
the same, it may well be that the healing process in the DED-
HSEs is slower than that observed in normal human skin
in vivo. This may arise from the fact that the DED-HSE ex vivo
model does not contain inflammatory cells and a blood
supply. Nevertheless, it is clear that the reepithelialization
data reported with this partial-thickness wound model are
consistent and demonstrate that this model can be used to
study wound responses in a way that mimics to some extent
in vivo wound healing.
Having established that the DED-HSEs can ‘‘heal,’’ the
effect of a novel VN:GF complex in facilitating healing of the
excisional wounds was evaluated. Of note, the VN:GF
complexes have previously been found to significantly in-
crease reepithelialization in a porcine deep dermal partial-
thickness burn model.38 Analysis of the partial-thickness
wounded DED-HSE models treated with the VN:GF using
MTT and histological analysis revealed enhanced cell mi-
gration, proliferation, and differentiation of keratinocytes at
FIG. 5. Development of a 4mm diameter full-thickness DED-HSE wound model and investigation of the effect of a
synthetic biomimetic gel on keratinocytes and fibroblasts. (a) Photograph of technique used to create the 4mm diameter full-
thickness wound in the DED-HSE. A wound was created using a 4mm biopsy punch, synthetic biomimetic gel was placed
into each full-thickness wound, and the DED-HSEs were cultured at the air:liquid interface for 14 days. (b–d) Immuno-
fluorescent analysis of healing full-thickness wounded DED-HSEs with the synthetic biomimetic gel. (b) 40-6-Diamidino-2-
phenylindole staining of the wounded DED-HSE seeded with keratinocytes. (c) Phalloidin rhodamine staining of the
wounded DED-HSE seeded with fibroblasts alone. (d) Pan-cytokeratin staining of the wounded DED-HSE seeded with
keratinocytes and fibroblasts. (e–g) Histological analysis of healing full-thickness wounded DED-HSE with the synthetic
biomimetic gel. (e) DEDHSEs seeded with keratinocytes; (f) DED-HSEs seeded with fibroblasts; and (g) DED-HSEs seeded
with keratinocytes and fibroblasts together. Black arrows indicate the initial wound boundary; and green arrows indicate
keratinocyte and fibroblast migration into the wound. Scale bars: 6mm (a), 0.4mm (b–d), and 100mm (e–g). Result for (d) was
observed once.
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the edges of the wounds (Fig. 3). These results are similar to
those observed in wounded DED-HSEs treated with serum-
containing FG medium and indicate the potential of VN:GF
as, first, a wound-healing therapy, and second, a defined
serum-free medium that could potentially replace the widely
utilized FG medium. Indeed, our laboratory recently re-
ported that primary keratinocytes can be successfully iso-
lated and cultured to reform an epidermal layer using a fully
defined, synthetic serum-free medium containing VN:GF.41
Moll et al. and Geer et al. have also previously used a
biopsy punch to create wounds on human skin and DED-
HSEs, respectively.23,30 However, Moll et al. used a method
that required the presence of serum to heal the wounds
created in the human skin, whereas Geer et al. used a DED-
HSE model that required grafting onto a mouse to facilitate
healing of the defects. Similarly, another two studies by
Bhora et al. and Andreadis et al. investigated the effects of
growth factors such as keratinocyte growth factor, fibroblast
growth factor, IGF-1, and EGF42,43 on human skin and the
DED-HSE wound healing, respectively. However, both of
these studies also required the presence of bovine serum
albumin or fetal calf serum. Our ability to study the healing
of wounds in the absence of poorly defined factors, such as
fetal calf serum and=or additives such as pituitary extract,
represents a significant advance in that it will facilitate the
study of wound healing in a defined environment, as well as
have wider utility in the animal-free development and test-
ing of consumer products.
We also describe the successful use of the DED-HSE for
mechanistic functional studies via examining the effect of a
growth factor treatment (VN:GF) in the presence of a growth
factor receptor function-blocking antibody (IGF-1R Ab). This
demonstrates that the 3D DED-HSE model has significant
utility for 3D mechanistic studies (Fig. 3e, f ). This is impor-
tant, as 2D culture systems provide cells with extremely
unnatural geometric, mechanical, and biochemical restric-
tions.44 Consequently, 2D monolayer cell culture systems
may result in unsatisfactory, misleading, and nonpredictive
data that have minimal relevance to the in vivo situation.45,46
The partial-thickness wounded DED-HSE models were
also used to test a synthetic biomimetic gel with features
designed to be similar to fibrin. During the wound healing
process in vivo, a fibrin clot forms and provides a primary
matrix for cells, assisting them to migrate and permeate the
FIG. 6. Investigation of cell attachment and protease cleavage motifs in the synthetic biomimetic gel on healing of full-
thickness wounded DED-HSEs seeded with fibroblasts. Hydrogel incorporating matrix metalloproteinase (MMP) cleavage
sites and RGD peptides (HydrogelþRGDþMMP), hydrogel incorporating MMP cleavage sites without RGD peptides
(Hydrogel%RGDþMMP), hydrogel incorporating RGD peptides without MMP cleavage sites (HydrogelþRGD%MMP),
collagen gel, and no gel were injected into full-thickness wounds created in DED-HSEs and cultured at the air:liquid interface
for 14 days. Samples were fixed and double-stained with 40-6-diamidino-2-phenylindole (nuclei, blue) and phalloidin rho-
damine (F-actin filament, red). Images were captured with a Leica SP5 Scanning Confocal Microscope. Scale bar: 250mm.
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wound site.47 There are two key features involved in this
process: (1) adhesion sites located in the matrix permit cells
to attach and migrate into the gel; and (2) the matrix reacts to
cell-derived proteolytic activity. This allows cells to degrade
the matrix locally by secreting plasmin or MMPs and then to
migrate into the matrix without constraint.47,48 The incor-
poration of RGD and MMP cleavage sites into the multiarm
PEG hydrogel described in earlier experiments enables this
gel (synthetic biomimetic gel) to imitate two essential bio-
logical functions of an extracellular matrix: cell adhesion and
protease degradation.49
A synthetic biomimetic gel mimicking a fibrin clot with
attributes that facilitate cell adhesion as well as degradation
of the gel by proteases has been developed by Ehrbar
et al.36,37 They have shown that this synthetic biomimetic gel
enhances the migration and proliferation of fibroblasts and
enables the formation of an interconnected cellular net-
work.36 Based on this, we hypothesized that keratinocyte
reepithelialization may also be accelerated by this synthetic
biomimetic gel. To explore this concept further, synthetic
biomimetic gels were injected into the wound areas after the
partial-thickness wounds were created in the DED-HSEs.
Results from the MTT analysis and histology demonstrated
that this gel was able to augment the migration, proliferation,
and differentiation of keratinocytes during partial-thickness
wound healing (Fig. 4). However, no significant difference
was observed in wounded DED-HSEs treated with hydrogel
incorporated with RGD peptides (synthetic biomimetic gel)
and hydrogel without RGD peptides. Therefore, we believe
that the enhanced cellular responses observed in the pres-
ence of the synthetic biomimetic gel may be aided by the
creation of a liquid:liquid-type interface with the cells at the
edges of the wounds. That is, the gels, which were hydrated
by the FG medium through absorption, provided moist en-
vironments facilitating enhanced migration of the keratino-
cytes. Indeed, the report by Gilje in 1948 suggested that
ulcers provided with a moist environment through an ad-
hesive bandage tape have enhanced healing, which supports
our data and the overall concept of ‘‘a moist environment to
facilitate optimal wound healing.’’50
To further characterize the synthetic gel, hydrogels
with=without MMP cleavage sites and with=without RGD
peptides were injected into full-thickness excisional wounds
in the DED-HSEs. Consistent with the findings of Ehrbar
et al.,36 we observed that with DED-HSEs seeded with der-
mal fibroblasts, the cells migrated into and proliferated
within hydrogel incorporating MMP cleavage sites and RGD
peptides (Figs. 5 and 6). The RGD peptides permitted cells to
attach and migrate into the gel, whereas the MMP cleavage
sites allowed the cells to degrade the matrix locally through
the secretion of endogenously produced MMPs. Interest-
ingly, with DED-HSEs seeded with keratinocytes alone, the
cells were not detected in the wound area. This may be due
to the fact that the synthetic biomimetic gel was rapidly
degraded by MMPs secreted by the keratinocytes and hence
did not provide the necessary physical scaffold to support
keratinocyte migration across the wound. However, when
keratinocytes were cocultured with fibroblasts together in
the DED-HSEs, the keratinocytes migrated across the wound
of the DED-HSE (Fig. 5), albeit this was only observed once.
All the same, it has been noted by others previously that
fibroblasts play a vital paracrine role in creating a balanced
microenvironment for the maintenance and repair of the
epidermis51–53 and this concept is supported by the data
reported here.
Although our results demonstrate the potential of the 3D
DED-HSE model for investigations into human skin repair, it
is important to bear in mind that the DED-HSEs do not re-
capitulate all aspects of wound repair, or they do not fully
represent a chronic wound. The major drawbacks of current
DED-HSEs are the absence of a blood supply, lack of a func-
tioning immune system, and limited wound contraction, al-
beit human wounds repair primarily via reepithelialization,
rather than contraction.We propose that through the addition
of additional skin cell types (e.g., melanocytes, Langerhans’
cells, microvascular endothelial cells), many of these criti-
cisms will be partially addressed and will facilitate the crea-
tion of a reliable DED-HSE platform technology. The isolation
of these cells from skin adjacent to wounds on limbs that have
been amputated due to a nonhealing wound may also rep-
resent a step forward. We recognize, however, that inclusion
of these cells does not create either a circulatory or nervous
system as present in vivo. Nevertheless, this approach will
facilitate an increased understanding of the interactions be-
tween cells that have key roles in skin biology. All the same, it
is important to recognize that this lack of vascularization in
the HSE models themselves may well be an advantage as the
wounds in the HSEs are somewhat hypoxic in comparison to
healthy skin,54 thereby mimicking more closely the hypoxic
in vivo chronic wound environment.
In summary, we report here the development of novel
approaches to create reproducible partial-thickness and full-
thickness wounds with a given size and depth in ex vivoDED-
HSEs. Additionally, our studies indicate that the novel VN:GF
growth factor combination not only heals excisional wounds
in these HSE models, but also provides a defined serum-free
ex vivo culture system for the DED-HSEs. Thus these models
will facilitate our understanding of human skin repair, re-
generation, and maintenance processes and coincidentally
provide a relevant in vitro tool for the assessment of potential
wound healing therapies in a defined, synthetic environment.
This will decrease our reliance on the use of animals for sci-
entific experimentation—an increasingly critical issue, espe-
cially given the European Union regulations (76=768=EEC,
February 2003) that prohibit the sale of consumer products
developed with testing that involves animals. In addition,
these models have allowed us to investigate and establish the
potential of the VN:GF and synthetic biomimetic gel tech-
nologies for the healing of partial- and full-thickness wounds,
contributing valuable new information that will further our
understanding of the effects of these novel wound healing
treatments. This is important for not only generating funda-
mental new information onwound healing processes, but also
for preclinical optimization of dosage, duration of therapies,
and treatment strategies, prior to clinical trials. Indeed, stud-
ies using these models are likely to be of greater benefit than
the numerous wound healing studies that are reported using
rodents and other small animals, as few of these translate well
to the clinical setting.
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